Posted by Michael Wonder on 29 Oct 2020
The FDA will not inspect vaccine production plants
29 October 2020 - Approval of a vaccine by the FDA typically requires inspection of the vaccine’s manufacturing plants.
In a COVID-19 world, this will not be the case. COVID-19 vaccine candidates will get a pass on FDA plant inspections, according to Bloomberg.
As candidates reach the final phases of testing, emergency use authorisation will be granted without pre-approval inspection, said FDA Director of Viral Products Jerry Weir.
